Publisher
Springer International Publishing
Reference23 articles.
1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition: DSM-5, Washington, DC: American Psychiatric Association, 2013.
2. Boland JR, Duffy B, Myer NM. Clinical utility of pharmacogenetics-guided treatment of depression and anxiety. Pers Med Psychiatry. 2018;7:7–13.
3. Breitenstein B, Scheuer S, Holsboer F. Are there meaningful biomarkers of treatment response for depression. Drug Discov Today. 2014;19:539–61.
4. Carvalho AF, Firth J, Vieta E. Bipolar disorder. N Engl J Med. 2020;383:58–66.
5. Caudill MM, Hunter AM, Cook IA, Leuchter A. The antidepressant treatment response index as a predictor of reboxetine treatment outcome in major depressive disorder. Clin EEG Neurosci. 2015;46:277–84.